This framework agreement aims to establish subsequent contracts for the procurement of medicines for the treatment of individuals with HIV/AIDS and for post-exposure treatment (2024-2025). The specific medications include BICTEGRAVIR, EMTRICITABINE, and TENOFOVIR in dosages of 50 mg/200 mg/25 mg, as
Contract awarded. Originally published 9 months ago.
This contract involves establishing subsequent contracts for the procurement of specialized road transport services for dialysis patients from 2026 to 2029. The specific details and quantities of the services required are outlined in the specifications document. Suppliers have 18 days to request cla
This framework agreement aims to establish subsequent contracts for the procurement of dialysis supplies for the period 2026-2029, as detailed in the specifications document. Suppliers have 18 days to request clarifications before the deadline for submitting offers. The contracting authority will pr
This contract involves establishing a framework agreement for the procurement of antiseptics and disinfectants for the years 2025 to 2028. Suppliers will be required to provide these products in accordance with the specifications and quantities outlined in the tender documents. Suppliers have 18 day
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
